证券代码：688602 证券简称：康鹏科技 公告编号：2024-043 上海康鹏科技股份有限公司 关于 2024 年半年度计提资产减值准备的公告 （二）资产减值损失 公司根据《企业会计准则第8号——资产减值》及公司会计政策，存货按照 成本与可变现净值孰低计量，并按单个存货项目计提存货跌价准备 20,543,967.29元。经测试，主要受2024年上半年显示材料库存耗用率低，新能 源电池材料、医药化学品中个别产品市场价格较低影响，公司本期存货跌价准备 计提23,510,690.10元、转回或转销29,038,266.92元。 三、计提资产减值准备对公司的影响 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、计提资产减值准备情况概述 根据《企业会计准则第 8 号——资产减值》及上海康鹏科技股份有限公司（以 下简称"公司"）会计政策、会计估计的相关规定，为客观、公允地反映公司截 至 2024 年 6 月 30 日的财务状况，经公司及下属子公司对应收账款、其他应收 款、存货等进行全面充分的评估和分析，认为上述资产中部分资产存在 ...

中信建投证券股份有限公司 关于上海康鹏科技股份有限公司 新增 2024 年度日常关联交易预计的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"保荐人"）作 为上海康鹏科技股份有限公司（以下简称"公司"、"康鹏科技"）首次公开发 行股票并在科创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管 指引第 1 号——规范运作》等相关规定，对康鹏科技新增 2024 年度日常关联交 易预计的事项进行了核查，具体情况如下： 公司于 2024 年 8 月 16 日召开了第二届董事会审计委员会第十二次会议，审 议通过了《关于新增 2024 年度日常关联交易预计的议案》，出席会议的委员一 致同意该议案。 公司于 2024 年 8 月 16 日召开第二届董事会第十七次会议和第二届监事会 第十七次会议，审议通过了《关于新增 2024 年度日常关联交易预计的议案》， 关联董事杨建华、杨重博回避表决。该议案无需提交公司股东大会审议。 （二）新增日常关联交易预计金额和类别 因公司日常生产经营需要，自 2024 年 1 月 1 日至 2024 年 ...

重要内容提示： ●是否需要提交股东大会审议：否 ●日常关联交易对公司的影响：本次新增关联交易内容属于公司日常关联交 易，系以日常经营业务为基础，以市场公允价格为定价依据，不存在影响公司独立 性或损害公司及股东利益的情形，公司不会对交易对手方形成依赖。 证券代码：688602 证券简称：康鹏科技 公告编号：2024-046 上海康鹏科技股份有限公司 关于新增 2024 年度日常关联交易预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、日常关联交易基本情况 （一）新增日常关联交易履行的审议程序 上海康鹏科技股份有限公司（以下简称"公司"）于2024年8月16日召开了第 二届董事会独立董事专门会议第二次会议，审议通过了《关于新增2024年度日常关 联交易预计的议案》，并经公司全体独立董事一致同意，形成以下意见：公司新增 2024年度日常关联交易预计属于公司日常经营业务，符合公司经营发展需要，符合 公司和全体股东的利益；该等日常关联交易遵循了公平、自愿的交易原则，审议程 序符合相关法律法规的规定，不存在违反法律、法规 ...

中信建投证券股份有限公司 关于上海康鹏科技股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"保荐人"）作 为上海康鹏科技股份有限公司（以下简称"公司"、"康鹏科技"）首次公开发 行股票并在科创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上市公司监管指引第 2 号——上市公司募 集资金管理和使用的监管要求》和《上海证券交易所科创板上市公司自律监管指 引第 1 号——规范运作》等相关规定，对康鹏科技使用部分闲置募集资金进行现 金管理的事项进行了核查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海康鹏科技股份有限公司首次公 开发行股票注册的批复》（证监许可[2023]1007 号），公司首次公开发行人民币 普通股 103,875,000 股，发行价格为每股人民币 8.66 元，共募集资金人民币 899,557,500.00 元，扣除承销保荐费用人民币 60,969,025.00 元（不含增值税）后 的募集资金为人民币 838,588,475.00 元，上述募集资金于 2023 ...

Company Information - The company's stock is listed on the Shanghai Stock Exchange's STAR Market under the ticker symbol 688602[12] - The company's registered and office address is located at 200-1, No. 2891 Qilianshan South Road, Putuo District, Shanghai[9] - The company's website is https://www.chemspec.com.cn and the investor relations email is ir@chemspec.com.cn[9] - The company's legal representative is Yang Jianhua[9] - The company's board secretary is Yang Chongbo, and the securities affairs representative is Zhang Xi[10] - The company's semi-annual report is available on the Shanghai Stock Exchange website at www.sse.com.cn[11] Financial Performance - Revenue for the reporting period decreased by 35.08% year-on-year to RMB 341.12 million, primarily due to declining demand in the new materials business and cyclical lows in CDMO orders[14][15] - Net profit attributable to shareholders of the listed company decreased by 88.12% year-on-year to RMB 8.69 million, mainly due to significant price declines and high fixed costs[14][15] - Basic earnings per share and diluted earnings per share both decreased by 88.89% year-on-year to RMB 0.02[15] - Total assets increased slightly by 0.23% to RMB 3.30 billion compared to the end of the previous year[14] - Non-recurring gains and losses amounted to RMB 39.47 million, including a significant gain of RMB 37.06 million from the partial equity transfer of an associate company[17][18] - Revenue for the first half of 2024 was RMB 3.411 billion, a decrease of 35.08% year-on-year, with main business revenue at RMB 3.280 billion, down 35.72%[31] - Display materials revenue increased by 19.02% to RMB 896.92 million, driven by a recovery in the panel industry since March 2023[31] - New energy battery materials and electronic chemicals revenue decreased by 24.01% to RMB 454.50 million, impacted by low product prices despite increased LiFSI shipments[31] - Organic silicon materials revenue fell by 33.63% to RMB 260.10 million due to lower-than-expected demand in the organic silicon pressure-sensitive adhesive sector[31] - CDMO sector revenue was RMB 1.668 billion, with a significant drop in overseas orders for new insecticides and patent drugs[31] - Operating costs decreased by 18.83% to 2.85 billion yuan due to reduced revenue and fixed manufacturing costs[34] - Cash and cash equivalents decreased by 48.60% to 669.30 million yuan, accounting for 20.26% of total assets[37] - Accounts receivable increased by 32.96% to 144.67 million yuan due to increased domestic sales with longer payment terms[37] - Short-term borrowings increased by 138.86% to 83.60 million yuan as the company replaced higher-cost long-term debt[38] - Overseas assets totaled 529.80 million yuan, accounting for 1.60% of total assets[40] - Investment activities generated a net cash outflow of 652.99 million yuan, primarily due to unredeemed financial products[35] R&D and Innovation - R&D investment as a percentage of revenue increased by 3.79 percentage points to 11.80%[15] - The company has accumulated 64 invention patents and 52 utility model patents, with a focus on fluorine-containing industrial chain products and carbon-carbon bond coupling technology[22] - In the reporting period, the company obtained 5 new invention patents and 11 new utility model patents, bringing the total to 64 invention patents and 52 utility model patents[24] - The company's R&D investment totaled 40.26 million yuan, a decrease of 4.38% compared to the same period last year, but the proportion of R&D investment to operating income increased by 3.79 percentage points to 11.8%[25] - The company is optimizing the process for OLED materials, with a project budget of 1.92 million yuan, aiming to achieve industrial-scale production levels[27] - The company is also optimizing the process for liquid crystal materials, with a project budget of 850,000 yuan, focusing on solving issues related to high-altitude low-pressure conditions[27] - The company is working on the process optimization of battery materials, with a project budget of 150,000 yuan, aiming to reduce manufacturing costs by recycling by-products[27] - R&D expenses totaled RMB 402.61 million, with significant investments in process optimization and development for organic silicon, pharmaceutical intermediates, and pesticide intermediates[28][29] - The company has 193 R&D personnel, accounting for 18.21% of total employees, with an average salary of RMB 107,347.67, up from RMB 95,547.25 in the previous year[30] - The company holds 116 national patents and has a robust R&D system with four specialized research groups focusing on display materials, new energy battery materials, pharmaceuticals, and pesticides[31] Corporate Governance and Shareholder Commitments - The company has no special arrangements for corporate governance during the reporting period[4] - The company has no plans for profit distribution or capital reserve to share capital conversion during the reporting period[4] - The company's controlling shareholders and their concerted parties have committed to not transferring or entrusting others to manage their shares for 36 months from the date of the company's stock listing[64] - If the company's stock price remains below the issue price for 20 consecutive trading days within 6 months of listing, the lock-up period for shares held by controlling shareholders will be automatically extended by 6 months[65] - Shareholders such as Yunding Investment and Kaishu Investment have committed to not transferring or entrusting others to manage their shares for 12 months from the date of the company's stock listing[66] - If the company's stock price remains below the issue price for 20 consecutive trading days within 6 months of listing, the lock-up period for shares held by shareholders like Yunding Investment and Kaishu Investment will be automatically extended by 6 months[67] - Shareholders including Wuxi Yunhui and Xingyu Huitian have committed to not transferring or entrusting others to manage their shares for 12 months from the date of the company's stock listing[68] - Shareholders such as Zhongqi Dongjian and Hainan Huipeng have committed to not transferring or entrusting others to manage their shares for 36 months from the date of acquiring the shares or 12 months from the date of the company's stock listing, whichever is later[69] - The company's actual controllers, including Yang Jianhua and Zha Yuezhen, have committed to not transferring or entrusting others to manage their shares for 36 months from the date of the company's stock listing[71] - If the company's stock price remains below the issue price for 20 consecutive trading days within 6 months of listing, the lock-up period for shares held by the actual controllers will be automatically extended by 6 months[72] - Directors and senior management personnel, except for Yang Chongbo, have committed to not transferring or entrusting others to manage their shares for 12 months from the date of the company's stock listing[73] - The company's stock lock-up period for key personnel will be automatically extended by 6 months if the closing price is below the IPO price within 6 months after listing[74][75] - Key personnel are restricted from transferring more than 25% of their shares annually during their tenure and for 6 months after leaving the company[75][80] - Core technical personnel are limited to transferring no more than 25% of their pre-IPO shares annually for 4 years after the lock-up period ends[82][83] - The controlling shareholder and its affiliates will not sell shares within the lock-up period and will extend the lock-up by 6 months if the stock price falls below the IPO price within 6 months after listing[84][85] - The controlling shareholder and its affiliates will maintain a minimum selling price not lower than the IPO price for 24 months after the lock-up period ends[86] - The company's controlling shareholders, Yang Jianhua, Zha Yuezhen, and Yang Zhongbo, have committed to not selling their shares before the lock-up period ends, and if the stock price falls below the IPO price for 20 consecutive trading days within 6 months of listing, the lock-up period will be automatically extended by 6 months[90][91] - After the lock-up period, controlling shareholders can only sell up to 25% of their shares annually, and if they leave the company, they cannot transfer shares within 6 months of resignation[92] - The company's major shareholders, including Wuxi Yunhui and Xingyu Huitian, have pledged to announce any share reduction plans at least 3 trading days in advance and report to the stock exchange 15 trading days before the first sale[97][99] - If the company's stock price triggers the stabilization mechanism, the company will implement measures to stabilize the stock price, with specific conditions and procedures outlined[100] - The company's stock price has been below the audited net asset value per share for 20 consecutive trading days, triggering the need for a stock price stabilization plan[101] - The company will implement a stock buyback plan if the stock price remains below the net asset value, with a minimum buyback amount of 20% of the previous year's net profit attributable to the parent company[105] - The company's controlling shareholder will increase their holdings if the buyback plan reaches its limit and the stock price still does not meet the stabilization conditions[107] - The controlling shareholder's total purchase amount for increasing holdings will not exceed 30% of the cumulative cash dividends received from the company since its listing[109] - Company directors and senior management will increase their holdings if the stock price remains below the net asset value after the buyback and controlling shareholder's increase in holdings[112] - The total purchase amount for directors and senior management to increase holdings will not exceed 30% of their after-tax salary and cash dividends received from the company during the period from the beginning of the previous year to the date of the board's approval of the stabilization plan[113] - The company's controlling shareholders and senior management are required to increase their shareholdings if the company's stock price does not meet the stabilization conditions after the share repurchase plan is implemented, with the total amount not exceeding 30% of the cumulative cash dividends received from the company since its IPO[123] - The company has established a stock price stabilization mechanism, including share repurchases and shareholding increases by controlling shareholders and senior management, to be triggered under specific conditions such as the stock price falling below the net asset value per share[120][122] - If the controlling shareholders fail to fulfill their shareholding increase obligations, the company has the right to withhold cash dividends equivalent to the amount required for the shareholding increase until the obligations are fulfilled[118] - Senior management and directors are required to increase their shareholdings within 10 trading days after the shareholders' meeting approves the stock price stabilization plan, with the total amount not exceeding 30% of their after-tax salary and cash dividends received from the company[129] - The company may reduce the cash dividends payable to controlling shareholders and use the equivalent amount for share repurchases if the controlling shareholders fail to fulfill their shareholding increase obligations[119] - The company has committed to stabilizing its stock price by not transferring shares held by individuals during the period of implementing the stabilization plan, unless approved by non-affiliated shareholders[130] - If the company fails to meet the listing conditions and has issued shares fraudulently, it will initiate a share repurchase program within 5 trading days after the relevant authorities confirm the facts[133] - The repurchase price will not be lower than the issuance price, and adjustments will be made for any stock splits, dividends, or other corporate actions[134] - The company's controlling shareholders and their affiliates have pledged not to interfere with the company's operations or harm its interests[139] - The company's actual controller has committed to not using unfair conditions to transfer benefits to other entities or individuals[141] - Directors and senior management have promised to act in the best interests of the company and its shareholders, avoiding any actions that could harm the company[142] - The company will adjust its repurchase price according to the regulations of the Shanghai Stock Exchange if there are any stock splits, dividends, or other corporate actions[138] - The company has committed to compensating investors for any losses incurred due to the failure to fulfill its share repurchase obligations[132] - The company will publicly explain and apologize if it fails to implement the stock price stabilization measures[131] - The company's controlling shareholders and their affiliates have agreed to comply with any new regulations issued by the China Securities Regulatory Commission regarding measures to protect investor returns[139] - The company has committed to complying with the "Company Law" and the "Shanghai Kangpeng Technology Co., Ltd. Articles of Association (Draft)" to ensure the rights of investors in terms of profit distribution[146] - The company has pledged to implement the "Shanghai Kangpeng Technology Co., Ltd. First Public Offering and Listing on the Science and Technology Innovation Board Post-IPO Three-Year Shareholder Dividend Return Plan" in full[147] - The company will initiate a share repurchase within 30 days if the prospectus is found to contain false statements or material omissions that affect the company's compliance with legal issuance conditions[151] - The company will compensate investors for direct economic losses if the prospectus contains false statements or material omissions that cause losses during securities issuance and trading[152] - The controlling shareholders and their concerted parties will also initiate a share repurchase and compensate investors for losses if the prospectus is found to contain false statements or material omissions[154] - The actual controller of the company will bear individual and joint legal responsibility for the authenticity, accuracy, and completeness of the prospectus content[156] - The company will strictly fulfill all public commitments made during the IPO process, including obligations and responsibilities[163] - If the company fails to fulfill its commitments due to non-force majeure reasons, it will take measures such as public apologies, halting public refinancing, and adjusting executive compensation[164][165] - In case of force majeure, the company will publicly explain the situation and apologize to shareholders and investors, while working to minimize investor losses[166] - The actual controller commits to compensating investors for direct losses if commitments are not fulfilled, using self-owned funds or as determined by regulatory authorities[167][168] - The actual controller will extend the lock-up period of their shares until all adverse effects from unfulfilled commitments are eliminated[168] - The actual controller will not receive dividends or bonus shares until all adverse effects from unfulfilled commitments are resolved[169] - Any profits obtained by the actual controller due to unfulfilled commitments will be returned to the company within five working days[169] - Shareholders holding more than 5% of the company's shares will also strictly fulfill their public commitments made during the IPO process[171] - The company will compensate public investors for direct losses incurred due to reliance on related commitments, with the amount determined through negotiation or regulatory authorities[172] - The lock-up period for shares held directly or indirectly by the company will be extended until all adverse effects caused by unfulfilled commitments are eliminated[173] - Any profits obtained by the company due to incomplete or ineffective fulfillment of commitments will be transferred to the issuer within five working days[174] - The company will publicly explain the reasons for not fully and effectively fulfilling commitments and apologize to shareholders and public investors[176] - The company will not directly or indirectly receive dividends or bonuses from the issuer until all adverse effects of unfulfilled commitments are eliminated[178] - In case of force majeure, the company will publicly explain the situation and propose new commitments if necessary[179] - The company and its controlling shareholders will not engage in any business activities that compete with the issuer's main business[181] - If unavoidable competitive activities arise, the company will transfer or terminate such businesses, with the issuer having priority to acquire them[183] - The company will ensure the issuer's independence in assets, business, personnel, finance, and organization[184] - The company will compensate for any losses caused by violations of the above commitments[185] - The company's actual controller and entities controlled by them do not engage in any business activities that directly or indirectly compete with the company's main business[186] - The company's actual controller commits to ensuring the independence of the company in terms of assets, business, personnel, finance, and organization[192] - The company's actual controller will take legal and effective measures to prevent entities under their control from engaging in business activities similar to the company's[193] - The company's controlling shareholder and their concerted parties will avoid related-party transactions with the company as much as possible[199] - For unavoidable related-party transactions, the company will ensure they are conducted on a fair and equitable basis, with prices determined by market standards or reasonable methods[199] - The company has committed to not using related-party transactions to transfer or divert profits, and to not exercising improper shareholder rights that could harm the company or other shareholders' interests[200] - The company has pledged to compensate for any economic losses caused by violations of the above commitments[200] Environmental and Social Responsibility - The company invested 8.19 million yuan in environmental protection during the reporting period[59] - The company has established mechanisms for environmental protection, including waste gas, wastewater, solid waste, and noise management[59] - The company has implemented pollution prevention facilities, such as water treatment, exhaust gas condensation, and RTO systems, which are operating normally[60] - The company has conducted environmental impact assessments and obtained necessary approvals for its projects[61] - The company has an emergency response plan for environmental incidents and conducted related drills during the reporting period[61] - The company has a self-monitoring plan for pollutants, ensuring all indicators meet emission standards[62] - The company has implemented carbon reduction measures, including optimizing production processes, increasing the proportion of new energy in the national grid, and upgrading equipment to reduce energy consumption[63] Business Operations and Strategy - The company's main products include display materials, new energy battery materials, electronic chemicals, and CDMO products for pharmaceuticals and pesticides[19] - The company's procurement model for major raw materials is based on planned procurement, with production and warehouse departments submitting approved material requisition forms, and the procurement department then formulating procurement plans based on these forms[20] - The company's sales model is direct sales, with customers divided into production enterprises and trading enterprises, and trading customers mainly purchasing on behalf of end customers[20] - The company operates in the fine chemical industry, focusing on new materials and CDMO sectors, with products requiring laboratory development, pilot testing, and scale-up production[21] - The company was recognized as a national-level "Little Giant" specialized and sophisticated enterprise in 2022[23] - The company has established long-term stable relationships with global industry-leading clients through strict EHS and quality assurance systems[31] - The company is actively expanding its OLED business and optimizing processes to reduce costs and improve efficiency in response to market competition and demand fluctuations[31] -

证券代码：688602 证券简称：康鹏科技 公告编号：2024-041 上海康鹏科技股份有限公司 关于 2024 年半年度募集资金存放与实际使用情况的 专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 根据中国证监会于2023年5月9日出具的《关于同意上海康鹏科技股份有限公司 首次公开发行股票注册的批复》（证监许可 [2023] 1007号）（以下简称"首次公开发 行"），公司获准向社会公开发行人民币普通股103,875,000股，每股面值为人民币1.00 元，每股发行价格为人民币8.66元，募集资金总额为人民币899,557,500.00元，扣除发 行费用后募集资金净额为人民币810,659,607.10元。截至2023年7月17日募集资金全部 到账后，已全部存放于经公司董事会批准开设的募集资金专项账户内管理。2023年7 月17日，毕马威华振会计师事务所（特殊普通合伙）出具了《验资报告》（毕马威华 振验字第2300834号），验证募集资金已全部到位。 ...

证券代码：688602 证券简称：康鹏科技 公告编号：2024-047 上海康鹏科技股份有限公司 关于第二届监事会第十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 上海康鹏科技股份有限公司（以下简称"公司"）第二届监事会第十七次会 议于 2024 年 8 月 16 日以现场方式召开。本次会议通知于 2024 年 8 月 6 日以直 接送达形式发送。本次会议应出席监事 3 人，实际出席监事 3 人，会议由监事会 主席范珠慧女士主持。会议的召开符合《中华人民共和国公司法》和《上海康鹏 科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定。 二、监事会会议审议情况 1.审议通过《关于 2024 年半年度报告及其摘要的议案》 监事会认为，公司 2024 年半年度报告及其摘要的编制和审议程序符合法律 法规和《公司章程》的相关规定；2024 年半年度报告及其摘要的内容与格式符合 中国证监会和上海证券交易所的相关规定，所包含的信息真实反映出公司报告期 内的经营情况和财务状况等事项；在半 ...

证券代码：688602 证券简称：康鹏科技 公告编号：2024-045 上海康鹏科技股份有限公司 关于为参股公司融资提供反担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 被担保人：中央硝子株式会社（以下简称"中央硝子"），与上海康鹏科技 股份有限公司（以下简称"公司"或"康鹏科技"）不存在关联关系。 本次担保类型：反担保 本次反担保涉及的债权本金：不超过 9,000 万元贷款额度（本金、利息、损害 金及其他根据贷款合同承担的全部债务的 40%），以最终签署的反担保合同为 准，已实际为其提供的反担保余额为 0 万元。 本次反担保已经公司第二届董事会第十七次会议、第二届监事会第十七次会 议审议通过，本议案无需提交公司股东大会审议。 一、反担保情况概述 （一）情况概述 公司的参股公司浙江中硝康鹏化学有限公司（以下简称"中硝康鹏"）为 满足日常经营发展的融资需要，向三井住友银行（中国）有限公司杭州分行 （以下简称"住友银行"）拟申请不超过人民币 9,000.00 万元贷款额度，中央硝 子为上述贷款本金、 ...

证券代码：688602 证券简称：康鹏科技 公告编号：2024-040 上海康鹏科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东的基本情况 截至本公告披露日，上海康鹏科技股份有限公司（以下简称"公司"或"康 鹏科技"）股东无锡云晖新汽车产业投资管理合伙企业（有限合伙）（以下简称"无 锡云晖"）持有公司股份 45,451,448 股,占总股本的 8.75%；宁波梅山保税港区 星域惠天投资管理合伙企业（有限合伙）（以下简称"星域惠天"）持有公司股份 5,513,760 股，占总股本的 1.06%。无锡云晖和星域惠天私募基金管理人均为北 京云晖投资管理有限公司，为一致行动人，合计持有公司股份 50,965,208 股， 占公司总股本的 9.81%。 股东桐乡云汇股权投资基金合伙企业（有限合伙）（以下简称"桐乡云汇"） 持有公司 14,427,584 股股份，占总股本的 2.78%；桐乡稼沃云枫股权投资合伙 企业（有限合伙）（以下简称"桐乡稼沃"）持有公司 ...

证券代码：688602 证券简称：康鹏科技 公告编号：2024-039 上海康鹏科技股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发战略配售股份（限售期 12 月）；股票认购方式为 网下，上市股数为 808.2909 万股。本公司确认，上市流通数量等于该限售期的全 部战略配售股份数量。 本次其余股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 15,572.1161 万股。 本次股票上市流通总数为 16,380.4070 万股。 本次股票上市流通日期为 2024 年 7 月 22 日。 一、本次上市流通的限售股类型 2023 年 5 月 9 日，经中国证券监督管理委员会《关于同意上海康鹏科技股份 有限公司首次公开发行股票注册的批复》（证监许可〔2023〕1007 号）同意注册， 上海康鹏科技股份有限公司（以下简称"公司"）首次公开发行人民币普通股（A 股）10,387.50 万股，并于 2023 年 7 月 20 日在上海证券 ...